Sucrose acetate isobutyrate as an In Sit
โ
Yaxin Lu; Yeling Yu; Xing Tang
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 238 KB
The objective of this study was to develop sustained-release sucrose acetate isobutyrate (SAIB) in situ formulations of risperidone for parenteral delivery. The formulations contained SAIB, solvent (anhydrous ethanol, ethyl lactate, or N-methyl-2-pyrrolidone), and additives such as polylactic acid (